title: Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
abstract: BACKGROUND
  Thyroid hormone suppression therapy is associated with decreased recurrence rates and improved survival in patients with differentiated thyroid cancer. Recently higher baseline thyrotropin (TSH) levels have been found to be associated with a postoperative diagnosis of differentiated thyroid cancer. Our objective was to confirm whether preoperative TSH levels were higher in patients who were diagnosed with differentiated thyroid cancer after undergoing thyroidectomy, compared with patients who were found to have benign disease. We also sought to determine whether thyroid hormone levels were lower in the patients with malignancy.
  
  
  METHODS
  The study was a retrospective analysis of a prospective study. The study setting was the General Clinical Research Center of an Academic Medical Center. Participants were 50 euthyroid patients undergoing thyroidectomy. Thyroxine, triiodothyronine (T(3)), and TSH levels were documented in patients prior to their scheduled thyroidectomy. Following thyroidectomy, patients were divided into those with a histologic diagnosis of either differentiated thyroid cancer or benign disease. Preoperative thyroid profiles were correlated with patients' postoperative diagnoses.
  
  
  RESULTS
  All patients had a normal serum TSH concentration preoperatively. One-third of the group was diagnosed with thyroid cancer as a result of their thyroidectomy. These patients had a higher serum TSH level (mean = 1.50 mIU/L, CI 1.22-1.78 mIU/L) than patients with benign disease (mean = 1.01 mIU/mL, CI 0.84-1.18 mIU/L). There was a greater risk of having thyroid cancer in patients with TSH levels in the upper three quartiles of TSH values, compared with patients with TSH concentrations in the lowest quartile of TSH values (odd ratio = 8.7, CI 2.2-33.7). Patients with a thyroid cancer diagnosis also had lower T(3) concentrations measured by liquid chromatography tandem mass spectrometry (mean = 112.6 ng/dL, CI 103.8-121.4 ng/dL) than did patients with a benign diagnosis (mean 129.9 ng/dL, CI 121.4-138.4 ng/dL).
  
  
  CONCLUSIONS
  These data confirm that higher TSH concentrations, even within the normal range, are associated with a subsequent diagnosis of thyroid cancer in individuals with thyroid abnormalities. This further supports the hypothesis that TSH stimulates the growth or development of thyroid malignancy during its early or preclinical phase. We also show for the first time that patients with thyroid cancer also have lower T(3) levels than patients with benign disease.
authors.affiliation: Division of Endocrinology, Georgetown University Medical Center, Washington, District of Columbia 20007, USA. jj@bc.georgetown.edu
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Jonklaas
authors.forename: Hala
authors.initials: H
authors.lastname: Nsouli-Maktabi
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Soldin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D011446:Prospective Studies; D012189:Retrospective Studies; D013964:Thyroid Neoplasms / Q000097:blood*; D013965:Thyroidectomy / Q000379:methods; D013972:Thyrotropin / Q000097:blood*; D014284:Triiodothyronine / Q000097:blood*
chemical_list: D014284:Triiodothyronine; D013972:Thyrotropin
references.citation: J Clin Endocrinol Metab. 1996 Dec;81(12):4318-23
references.pmid: 8954034
references.citation: Am Surg. 2005 Oct;71(10):874-8
references.pmid: 16468540
references.citation: J Clin Endocrinol Metab. 2007 Jul;92(7):2610-5
references.pmid: 17426094
references.citation: Lancet. 1954 Apr 17;266(6816):812-3
references.pmid: 13153121
references.citation: Clin Endocrinol (Oxf). 2005 Jun;62(6):672-8
references.pmid: 15943828
references.citation: J Clin Endocrinol Metab. 2006 Nov;91(11):4295-301
references.pmid: 16868053
references.citation: Cancer. 1998 Sep 1;83(5):1012-21
references.pmid: 9731906
references.citation: Thyroid. 2006 Dec;16(12):1229-42
references.pmid: 17199433
references.citation: J Clin Endocrinol Metab. 2008 Apr;93(4):1224-30
references.pmid: 18230665
references.citation: J Clin Endocrinol Metab. 2002 Feb;87(2):489-99
references.pmid: 11836274
references.citation: Int J Radiat Oncol Biol Phys. 1988 Jun;14(6):1063-75
references.pmid: 2454902
references.citation: Ann Med. 2002;34(7-8):554-64
references.pmid: 12553495
references.citation: Arch Surg. 1998 Apr;133(4):419-25
references.pmid: 9565123
references.citation: Surgery. 1999 Dec;126(6):1070-6; discussion 1076-7
references.pmid: 10598190
references.citation: Thyroid. 1995 Feb;5(1):35-40
references.pmid: 7787431
references.citation: J Clin Endocrinol Metab. 1976 Feb;42(2):395-8
references.pmid: 177443
references.citation: J Nucl Med. 1980 Aug;21(8):733-7
references.pmid: 7400828
references.citation: J Am Coll Surg. 2007 May;204(5):764-73; discussion 773-5
references.pmid: 17481480
references.citation: Eur J Surg Oncol. 1994 Dec;20(6):613-21
references.pmid: 7995409
references.citation: Clin Chim Acta. 2004 May;343(1-2):185-90
references.pmid: 15115693
references.citation: Annu Rev Physiol. 2000;62:439-66
references.pmid: 10845098
references.citation: Cancer. 1995 Dec 1;76(11):2312-8
references.pmid: 8635037
references.citation: J Clin Endocrinol Metab. 2006 Nov;91(11):4253-5
references.pmid: 17088441
references.citation: J Clin Endocrinol Metab. 2007 Dec;92(12):4575-82
references.pmid: 17911171
references.citation: Am J Med. 1994 Nov;97(5):418-28
references.pmid: 7977430
references.citation: Am J Surg. 1990 Oct;160(4):344-7
references.pmid: 2221232
references.citation: Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):32-40
references.pmid: 16929364
references.citation: Adv Ther. 2007 May-Jun;24(3):510-6
references.pmid: 17660159
references.citation: Surgery. 1985 May;97(5):539-46
references.pmid: 2986305
references.citation: Thyroid. 1998 Sep;8(9):737-44
references.pmid: 9777742
references.citation: J Clin Endocrinol Metab. 1981 Jan;52(1):23-8
references.pmid: 6256403
references.citation: J Clin Endocrinol Metab. 2008 Mar;93(3):809-14
references.pmid: 18160464
references.citation: JAMA. 2008 Feb 20;299(7):769-77
references.pmid: 18285588
references.citation: J Clin Endocrinol Metab. 1999 Mar;84(3):829-34
references.pmid: 10084556
references.citation: Arch Surg. 1988 May;123(5):569-74
references.pmid: 3358683
references.citation: J Clin Endocrinol Metab. 1980 Oct;51(4):915-20
references.pmid: 7419673